Next Article in Journal
The Role of Systematic Lymphadenectomy in Low-Grade Serous Ovarian Cancer: A Systematic Review and Meta-Analysis
Previous Article in Journal
Prevalence of and Impact on the Outcome of Myosteatosis in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
Previous Article in Special Issue
Treatment of Acute Myeloid Leukemia in Older Adults
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Srinivasan Rajsri et al. Acute Myeloid Leukemia Stem Cells in Minimal/Measurable Residual Disease Detection. Cancers 2023, 15, 2866

by
Kritika Srinivasan Rajsri
1,2,
Nainita Roy
1 and
Sohini Chakraborty
1,*
1
Department of Pathology, New York University Grossman School of Medicine, New York, NY 10016, USA
2
Department of Molecular Pathobiology, New York University College of Dentistry, New York, NY 10010, USA
*
Author to whom correspondence should be addressed.
Cancers 2024, 16(5), 954; https://doi.org/10.3390/cancers16050954
Submission received: 21 August 2023 / Accepted: 15 November 2023 / Published: 27 February 2024
(This article belongs to the Special Issue Acute Myeloid Leukemia: The Future Is Bright)

Missing Citation

In the original publication [1], ref. [84] was not cited. The citation has now been inserted in Figure 1 caption and should read:
84. Hourigan, C.S.; Karp, J.E. Minimal residual disease in acute myeloid leukaemia. Nat. Rev. Clin. Oncol. 2013, 10, 460–471. https://doi.org/10.1038/nrclinonc.2013.100.

Figure Legend

In the original publication, there was a mistake in the illustration and legend for Figure 1. The graph at the bottom of the figure was improperly labeled in the X-axis, and the figure legend was not written correctly. The correct illustration and legend appear below.
Figure 1. A schematic illustration and description of the clinical MRD detection methods. Panels: 1. Morphology, 2. MFC, 3. PCR, and 4. NGS [18]. Panel 2.2 also demonstrates the LSC investigational detection methods recommended for evaluation in clinical studies [70]. Panel 5 describes the detection threshold of the various detection methods, and is inspired by [84] (Figure 1).
Figure 1. A schematic illustration and description of the clinical MRD detection methods. Panels: 1. Morphology, 2. MFC, 3. PCR, and 4. NGS [18]. Panel 2.2 also demonstrates the LSC investigational detection methods recommended for evaluation in clinical studies [70]. Panel 5 describes the detection threshold of the various detection methods, and is inspired by [84] (Figure 1).
Cancers 16 00954 g001
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Srinivasan Rajsri, K.; Roy, N.; Chakraborty, S. Acute Myeloid Leukemia Stem Cells in Minimal/Measurable Residual Disease Detection. Cancers 2023, 15, 2866. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Srinivasan Rajsri, K.; Roy, N.; Chakraborty, S. Correction: Srinivasan Rajsri et al. Acute Myeloid Leukemia Stem Cells in Minimal/Measurable Residual Disease Detection. Cancers 2023, 15, 2866. Cancers 2024, 16, 954. https://doi.org/10.3390/cancers16050954

AMA Style

Srinivasan Rajsri K, Roy N, Chakraborty S. Correction: Srinivasan Rajsri et al. Acute Myeloid Leukemia Stem Cells in Minimal/Measurable Residual Disease Detection. Cancers 2023, 15, 2866. Cancers. 2024; 16(5):954. https://doi.org/10.3390/cancers16050954

Chicago/Turabian Style

Srinivasan Rajsri, Kritika, Nainita Roy, and Sohini Chakraborty. 2024. "Correction: Srinivasan Rajsri et al. Acute Myeloid Leukemia Stem Cells in Minimal/Measurable Residual Disease Detection. Cancers 2023, 15, 2866" Cancers 16, no. 5: 954. https://doi.org/10.3390/cancers16050954

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop